載入...
Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy
First-line chemotherapy to combat primary malignant brain cancer is often accompanied by lymphopenic immunologic deficiency. Although counterintuitive, chemotherapy-induced lymphopenia can provide excellent host conditioning that may actually be leveraged to potentiate antitumor immunotherapy. We di...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292586/ https://ncbi.nlm.nih.gov/pubmed/25610727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.944054 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|